Stay updated on Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page's revision is updated from v3.5.4 to v3.5.5, signaling a new build of the page content. The content described in the page remains unchanged.
    Difference
    0.0%
    Check dated 2026-06-08T15:48:58.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Melanoma is added as a condition label and MedlinePlus Genetics is listed under related topics, improving navigation to disease context and genetics resources on the page.
    Difference
    0.1%
    Check dated 2026-05-25T08:23:41.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A new Revision: v3.5.4 tag was added and older items including Melanoma, related topics, MedlinePlus Genetics, and Revision: v3.5.3 were removed, indicating a small site-wide update rather than changes to the trial content.
    Difference
    0.1%
    Check dated 2026-05-18T04:01:09.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The Taiwan location label was updated from 'Taoyuan District, Taiwan, 333' to 'Taoyuan, Taiwan, 333' in the Locations list, preserving the same postal code and reflecting a standardized city name.
    Difference
    0.0%
    Check dated 2026-05-03T19:34:42.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Updated the “related topics”/glossary area to reflect the sponsor name branding (“Ono Pharmaceutical Co., Ltd.”) and added the associated “Revision: v3.5.3” site version marker, replacing the previous “Revision: v3.5.0” and slightly different formatting.
    Difference
    0.1%
    Check dated 2026-04-26T15:42:56.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The term 'Melanoma' and the MedlinePlus Genetics related topic reference are removed from the page, diminishing visibility of the study's focus and its related resources.
    Difference
    0.1%
    Check dated 2026-04-12T11:48:32.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.